Literature DB >> 21198721

Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics.

B Cryder1, M Felczak, J Janociak, L Dela Pena, S Allen, P Gutierrez.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: There is wide inter-patient and intra-patient variability in the pharmacodynamic profile of warfarin. To determine the prevailing aetiologies of non-therapeutic warfarin anticoagulation episodes among patients currently enrolled in an outpatient anticoagulation clinic and compare the relative frequency in which they occur compared to therapeutic anticoagulation regimens.
METHODS: Prospective, observational cohort study set within three pharmacist-managed anticoagulation clinics in a community outpatient health system. Patients were included, if they were seen for an office visit during the 6-month period from September 2006 to March 2007 and evaluated for the presence or absence of 12 investigational factors linked to non-therapeutic anticoagulation results. Multivariate stepwise logistic regression performed to assess predictive value of each factor.
RESULTS: A total of 5817 patient-visits were documented producing 2886 (49.6%) non-therapeutic and 2931 (50.4%) therapeutic International Normalized Ratio (INR) readings. The most prevalent aetiologies linked to non-therapeutic INR results included change in dietary vitamin K intake (16.9%, OR 6.4), non-compliance (15.0%, OR 4.9), and initiation of anticoagulant therapy (9.9%, OR 2.3). The factor with the highest predictive value of non-therapeutic INR results was a change in health status (OR 9.5) despite its lower rate of frequency (4.9%). Despite identification of many causative factors in this study, 40.2% of non-therapeutic INR readings had no known aetiology. In the end, the lack of any study factor was a greater predictor of therapeutic anticoagulation (86.2%), than the presence of a study factor was for predicting non-therapeutic INR values (51.4%). WHAT IS NEW AND
CONCLUSION: Change in health status was the strongest predictor of non-therapeutic INR levels out of the investigational factors evaluated. Our study demonstrated that there are many aetiologies for non-therapeutic INR values that were not explained by our investigational factors.
© 2010 The Authors. JCPT © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21198721     DOI: 10.1111/j.1365-2710.2009.01155.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  2 in total

1.  Pharmacist's interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial.

Authors:  Slaven Falamić; Marko Lucijanić; Maja Ortner Hadžiabdić; Srećko Marušić; Vesna Bačić Vrca
Journal:  Int J Clin Pharm       Date:  2018-07-26

Review 2.  Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.

Authors:  Daniel M Witt; Nathan P Clark; Scott Kaatz; Terri Schnurr; Jack E Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.